Reply to the commentary: “Regression residual vs. Bayesian analysis of medicinal floras”  by Leonti, Marco et al.
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Since our paper introducing the Bayesian approach for the anal-
sis of over- and underused taxonomic groups (Weckerle et al.,
011) addressed ﬁrstly the ﬂaws in Bennett and Husby’s (2008)
inomial method, Moerman’s advocacy for regression analysis
omes somewhat unexpectedly. Moerman’s critical commentary is
n large part an anecdotally referenced historical account of regres-
ion analysis. However, that regression analysis and the Binomial
ethod have been repeatedly used (including by ourselves: cf.
eonti et al., 2003, 2009) does not in itself testify to their infallibility
cf. Leonti, 2011).
That the medicinal ﬂora is not a random selection has already
een made clear by Dioscorides (cf. Matthioli, 1568; Berendes,
902). Although they did not rely on the concept of higher plant
axa, classical and Renaissance medicinal plant experts and phar-
acognosists were well aware that some “kind of plants” were
ore heavily relied upon as medicine than others (cf. Tschirch,
910). We  agree with Moerman that quantitatively comparing the
edicinal ﬂora with the overall ﬂora and testing speciﬁc taxa for
ver- and underuse is a “useful and interesting way  to proceed” and
ence addressed the questions posed by Moerman (1979) by intro-
ucing a more scientiﬁcally robust Bayesian method (cf. Weckerle
t al., 2011). We  try to address here the methodological issues and
isagreements raised in Moerman’s commentary.
The central point addressed by our critics concerns the statisti-
al model used to represent the available data. In fact, Bennett and
usby (2008) used the same statistical model as we do, namely the
inomial one, but with a different approach towards estimation.
his is because percentages play a central role in their approach,
eing the maximum likelihood estimators of the true proportion of
ses. We  avoid this approach and opted for the Bayesian method, in
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Open access under CC BY-NC-ND license.acknowledgement of the highly recognized serious questions and
answers (and the rejoinder) raised in the article by Gelman (2008),
which we encourage all those interested in this discussion to con-
sult. In fact, in the rejoinder (Section 2) Gelman points out that the
“challenge comes in constructing realistic models and in assess-
ing their ﬁt”. This is exactly our point in criticizing the regression
analysis approach. References on standard Bayesian analysis are
indicated in the textbook by Gelman et al. (2003).
On one particular point we  (Weckerle et al., 2011) and Moer-
man  seem to agree: regression analysis privileges large families.
But while Moerman argues that there is “a very good reason to
privilege large families because that’s where medicinal plants are”
we consider such circular reasoning as non-scientiﬁc. The ques-
tion here is “where are the medicinal plants?” and not “where are
the medicinal plants in the large families?” To answer the ques-
tion whether a medicinal ﬂora departs from a random selection, all
families have to be considered equally, independent of their size.
The Bayesian analysis does neither “privilege” small plant families
nor does it “ignore” large ones and Bayesian analysis is not based
on percentage calculation either.
Why  does the regression analysis privilege large families? “This
is because the residual of a relatively small plant family (e.g. n = 10)”
may  hypothetically achieve a value < |10|, “while a relatively large
plant family (e.g. n = 100) may  get a residual” <|100|. Moerman has
spotted it very well – it’s not “maximally” 10 or 100 but larger
than −10 and smaller than +10 or larger than −100 or smaller
than +100. This does not change anything in our argumentation.
The problem is that regression analysis lumps all plant families
together as if small families may  achieve residuals with the same
order of magnitude as large families. Figs. 1 and 2 show the asso-
ciation between regression residuals and family size based on
our dataset from Campania and highlight again that the result
of regression analysis is an artifact of family size and regression
approach.
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Furthermore, the lack of inferential data analysis renders the
nterpretation of regression analysis very subjective and leaves it
pen to arbitrary argumentation. Moerman exempliﬁes it himself
y suggesting that anyone interested in the smaller families might
liminate the larger families in any way one prefers (calling them
utliers), and repeating the regression residual analysis [sic!]. The
roblem is that large families or outliers cannot be mathematically
eﬁned, which inevitably leads to arbitrariness. Thus, the theory
roposing a global pattern of medicinal plant knowledge, put for-
ard by Moerman and colleagues (1999) and based on results
btained with the regression analysis needs further veriﬁcation
ith a more robust method such as the Bayesian. This approach
ore accurately represents a random mechanism for “the result
f generations of human beings studying nature”, as argued by
oerman.
Why  is it important to treat all families equally? Plant families
s all other supraspeciﬁc ranks in the Linnean hierarchy are a mat-
er of convenience and today often a matter of consensus among
eading researchers in the ﬁeld (e.g. history of APG I–III). Only the
ircumscription of clades (a collection of lineages descended from
 common ancestor) as currently favored by phylogenetic systema-
ists has a sound scientiﬁc basis. The assignment of a certain rank to
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such clades is not ﬁxed. Thus, the size and circumscription of spe-
ciﬁc families and higher taxonomic ranks is changeable. While this
is not “the result of some statistical trick” it will, however, heavily
inﬂuence regression analysis. For instance, in our regression anal-
ysis of the Popoluca medicinal ﬂora the Fabaceae (s.l.) obtained
the third highest residual (cf. Leonti et al., 2003). Using a different
possible taxonomic classiﬁcation, i.e. separating the Fabaceae into
Caesalpiniaceae, Fabaceae and Mimosaceae, would have launched
all three families into the midﬁeld of the residual ranking. With
the Bayesian method, however, the results would not have been
affected by such a taxonomic variation because it is a more robust
approach, which generates more coherent results.
A survey of medicinal plants is never a census, it is only ever
a sample. During the ﬁst author’s ﬁeldwork with the Popoluca, in
Mexico, he interviewed 72 specialists who  named 614 medicinal
species and “new” medicinal plants were also shown to him by
the last few healers interviewed (Leonti et al., 2003). We  argue
that exhaustive ﬁeldwork would lead to a medicinal ﬂora congru-
ent with the total ﬂora and represent a considerable proportion of
personal (individual) knowledge and beliefs and hence including
data without cultural consensus. However, since no ﬁeld worker
interviews the whole population (in the case of the Popoluca, ca.
50.000 people) such data is always a more or less representative
sample. Because of this fact, the analysis has to rely on statistical
approaches, which are based on probabilities, such as the Bayesian
approach proposed in the paper under discussion.
Our approach was not limited to plant families only but
also included the higher taxonomic groups: Pteridophytes, Gym-
nosperms, early diverging Angiosperms, Monocots, early diverging
Eudicots, Rosids, and Asterids (cf. Weckerle et al., 2011). Bayesian
analysis at this taxonomic level showed that the probability for a
common proportion of medicinal plants is very low and that it is
to be rejected because two  of the 95% credible intervals for the
proportion of uses of taxonomic groups differ from the common
proportion of medicinal species (in fact Monocots are underused
and early diverging Eudicots overused, see graphical abstract).
Therefore, the hypothesis of a common proportion underlying the
regression analysis does not hold. The regression analysis is based
on the assumption that medicinal plants are distributed in equal
proportions across taxonomic groups, with the calculated regres-
sion coefﬁcient supposedly representing this common proportion.
Neither regression analysis nor Bayesian analysis of medicinal
ﬂoras serve, by themselves, as tools for bioprospecting purposes.
However, a combination of the Bayesian method with a chi-square
analysis of the association between use categories and taxonomic
groups may  lead to interesting ethnopharmacological hypotheses
(Weckerle et al., 2011), in the attempt to differentiate between
medicinal plant selection driven by pharmacological properties on
the one hand and cognitive features, ecological factors and cultural
history on the other (cf. Leonti, 2011).
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